Balchem Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Balchem Corporation on May 20, 2011, regarding corporate governance changes. The report details the departure of a senior officer and the subsequent appointment of a replacement within the Research and Development division.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure: Dr. Paul Richardson, Vice President of Research and Development, resigned effective June 1, 2011.
- Appointment: Dr. Akash Tayal was promoted to Vice President of Research and Development, effective immediately upon Dr. Richardson's resignation.
- Background: Dr. Tayal joined the company in August 2005 and most recently served as Director of Research, leading product technology developments in animal health, food, and industrial applications.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on strategy, or specific risk factors. The document is limited to the announcement of the executive transition.
Key Facts for Investor Verification
- Confirm the effective date of Dr. Richardson's resignation (June 1, 2011).
- Verify Dr. Tayal's tenure and prior role as Director of Research.
- Check for any subsequent filings regarding compensation arrangements for the new appointee, as this 8-K does not detail specific terms.